 The novel coronavirus, NCOV, also known as COVID-19, is caused by the SARS-COV-2 virus. It has been shown that this virus can bind to the ACE2 protein on the surface of lung cells, which allows it to enter the cell and replicate itself. In this study, researchers have identified another potential target for the virus, the EGFR protein found on the surface of lung cells. They found that when the virus binds to the EGFR protein, it activates the ERK1-2 and AKT kinases, leading to increase survival expression and ultimately increasing the survival rate of the virus. This could lead to new treatments for NCOV infection, such as targeting the EGFR protein with drugs or antibodies. This article was offered by Abdul Rashid Palakot, Aisha Al-Niadi, Khalid Muhammad, and others.